Immigration and screening programs for hemoglobinopathies in Italy, Spain and Turkey
Canatan, Duran (Thalassemia Diagnosis Center of Mediterranean Blood Diseases Foundation)
Vives Corrons, Juan Luís (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Piacentini, Giorgio (Private Accredited Quisisana Hospital)
Kara, Fatih (General Directory of Public Health of MOH of Turkey)
Keskinkılıç, Bekir (General Directory of Public Health of MOH of Turkey)
Tezel, Başak (General Directory of Public Health of MOH of Turkey)
Uğur, Aslıhan Külekçi (General Directory of Public Health of MOH of Turkey)
Babayiğit, Meliha (General Directory of Public Health of MOH of Turkey)
Krishnevskaya, Elena (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Millimaggi, Giuseppe (Private Accredited Quisisana Hospital)
Erinekçi, Ozlem (Thalassemia Diagnosis Center of Mediterranean Blood Diseases Foundation)
Özdemir, Zekiye (Thalassemia Diagnosis Center of Mediterranean Blood Diseases Foundation)
De Sanctis, Vincenzo (Private Accredited Quisisana Hospital)
Universitat Autònoma de Barcelona

Data:	2021
Resum:	Sickle cell disease (SCD) and thalassemias are the most common monogenic diseases in the world. The number of migrants and refugees in Europe and Turkey, in the past decade, has increased dramatically due to war, violence or prosecutions in their homeland. Prevention and management of haemoglobin disorders is well established and managed in countries where these conditions were traditionally endemic or in countries that have a longstanding tradition of receiving migrants. Therefore, preventive and diagnostic programmes regarding hemoglobinopathies in immigrant populations have been implemented. The purpose of this paper it to report a summary of the experience gained in Italy, Spain and Turkey in migrants, asylum seekers and refugees. (www. actabiomedica. it).
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Hemoglobinopathies ; Migrants ; Refugees ; Turkey ; Spain ; Italy ; Equality Plus Project
Publicat a:	Acta Biomedica, Vol. 92 Núm. 4 (february 2021) , p. e2021410, ISSN 2531-6745

DOI: 10.23750/abm.v92i4.11965
PMID: 34487057

11 p, 2.4 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP) > Institut de Recerca contra la Leucèmia Josep Carreras
Articles > Articles de recerca
Articles > Articles publicats